Sultana Marcia Zalalee

Array ( [id] => 6134369 [patent_doc_number] => 20020078472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'METHODS AND MEANS FOR EXPRESSION OF MAMMALIAN POLYPEPTIDES IN MONOCOTYLEDONOUS PLANTS' [patent_app_type] => new [patent_app_number] => 09/333527 [patent_app_country] => US [patent_app_date] => 1999-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12679 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20020078472.pdf [firstpage_image] =>[orig_patent_app_number] => 09333527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151262 [patent_doc_number] => 06156314 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon' [patent_app_type] => 1 [patent_app_number] => 9/332978 [patent_app_country] => US [patent_app_date] => 1999-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 46 [patent_no_of_words] => 28153 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156314.pdf [firstpage_image] =>[orig_patent_app_number] => 332978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416280 [patent_doc_number] => 06525173 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Process for expression and production of recombinant protein hybrid protein (p24/p17) derived from human immunodeficiency viruses (HIV-1)' [patent_app_type] => B1 [patent_app_number] => 09/142141 [patent_app_country] => US [patent_app_date] => 1999-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4127 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525173.pdf [firstpage_image] =>[orig_patent_app_number] => 09142141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4316560 [patent_doc_number] => 06242574 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Antimicrobial proteins' [patent_app_type] => 1 [patent_app_number] => 9/091590 [patent_app_country] => US [patent_app_date] => 1999-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 9162 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242574.pdf [firstpage_image] =>[orig_patent_app_number] => 091590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6885504 [patent_doc_number] => 20010039669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-08 [patent_title] => 'VIRAL CHIMERAS COMPRISED OF CAEV AND HIV-1 GENETIC ELEMENTS' [patent_app_type] => new [patent_app_number] => 09/302171 [patent_app_country] => US [patent_app_date] => 1999-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9938 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20010039669.pdf [firstpage_image] =>[orig_patent_app_number] => 09302171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6883358 [patent_doc_number] => 20010049830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'MOLECULAR FARMING' [patent_app_type] => new [patent_app_number] => 09/287447 [patent_app_country] => US [patent_app_date] => 1999-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5082 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049830.pdf [firstpage_image] =>[orig_patent_app_number] => 09287447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1193524 [patent_doc_number] => 06730838 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-04 [patent_title] => 'Opiumless and alkaloid-free non-narcotic opium poppy (Papaver somniferum) variety Sujata ' [patent_app_type] => B1 [patent_app_number] => 09/276720 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4542 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730838.pdf [firstpage_image] =>[orig_patent_app_number] => 09276720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254242 [patent_doc_number] => 06207801 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same' [patent_app_type] => 1 [patent_app_number] => 9/276993 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 11914 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207801.pdf [firstpage_image] =>[orig_patent_app_number] => 276993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4413934 [patent_doc_number] => 06193983 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Equine herpesvirus glycoproteins' [patent_app_type] => 1 [patent_app_number] => 9/267384 [patent_app_country] => US [patent_app_date] => 1999-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 26 [patent_no_of_words] => 13922 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/193/06193983.pdf [firstpage_image] =>[orig_patent_app_number] => 267384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460605 [patent_doc_number] => 06392029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'HIV chemokines' [patent_app_type] => B1 [patent_app_number] => 09/249542 [patent_app_country] => US [patent_app_date] => 1999-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 17342 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/392/06392029.pdf [firstpage_image] =>[orig_patent_app_number] => 09249542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4148510 [patent_doc_number] => 06106843 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Process for the isolation of a nontoxinogenic vibrio cholerae strain and a process for preparing cholera vaccine from said vibrio cholerae strain' [patent_app_type] => 1 [patent_app_number] => 9/243810 [patent_app_country] => US [patent_app_date] => 1999-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13342 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/106/06106843.pdf [firstpage_image] =>[orig_patent_app_number] => 243810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1579715 [patent_doc_number] => 06448471 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Nematode-feeding structure specific gene and its application to produce nematode resistant plants' [patent_app_type] => B1 [patent_app_number] => 09/234827 [patent_app_country] => US [patent_app_date] => 1999-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16706 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448471.pdf [firstpage_image] =>[orig_patent_app_number] => 09234827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440744 [patent_doc_number] => 06495740 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Manipulation of cellulose and/or -1,4-Glucan' [patent_app_type] => B1 [patent_app_number] => 09/221013 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 45560 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495740.pdf [firstpage_image] =>[orig_patent_app_number] => 09221013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521693 [patent_doc_number] => 06414116 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Immunoreactive regions of glycoprotein GPII of varicella zoster virus' [patent_app_type] => B1 [patent_app_number] => 09/219797 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4985 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414116.pdf [firstpage_image] =>[orig_patent_app_number] => 09219797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4263208 [patent_doc_number] => 06204434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Materials and methods for the modification of plant lignin content' [patent_app_type] => 1 [patent_app_number] => 9/211710 [patent_app_country] => US [patent_app_date] => 1998-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6018 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204434.pdf [firstpage_image] =>[orig_patent_app_number] => 211710 [rel_patent_id] =>[rel_patent_doc_number] =>)